Skip to main content
ACR Convergence 2023 Main banner
Final Program


Schedule at a Glance
Legend
Session Format
In Person
In Person
Livestreamed
Livestreamed
On Demand
On Demand
Back

Anisha Dua, MD, MPH

Northwestern University
Chicago, IL, United States

Dr. Dua is an Associate Professor, Rheumatology Fellowship Program Director, and the Director of the Vasculitis Center at Northwestern University. She is highly involved in education initiatives, serving as co-chair of the ACR workforce solutions education committee, member of the MKSAP rheumatology ACP committee, and a member of the scientific advisory council for the Rheumatology Research Foundation. Her clinical focus is vasculitis where she helped to develop the ACR/VF guidelines in vasculitis management and is on the Vasculitis Foundation board of directors.

Presentation(s):

  • Clinician Educator Career I

    Friday, November 10, 2023
    3:45 PM – 4:05 PM PT

    Disclosure(s): AbbVie/Abbott: Advisor or Review Panel Member (Ongoing); chemocentryx: Advisor or Review Panel Member (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Novartis: Advisor or Review Panel Member (Ongoing); sanofi: Consultant (Ongoing)

  • 0685: Efficacy and Safety of Avacopan in Patients with ANCA-Associated Vasculitis Receiving Rituximab in a Phase 3 Trial

    Sunday, November 12, 2023
    9:00 AM – 11:00 AM PT

    Disclosure(s): AbbVie/Abbott: Advisor or Review Panel Member (Ongoing); chemocentryx: Advisor or Review Panel Member (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Novartis: Advisor or Review Panel Member (Ongoing); sanofi: Consultant (Ongoing)

  • 12S146: Abstracts: Professional Education (0763–0768)

    Sunday, November 12, 2023
    2:00 PM – 3:30 PM PT

    Disclosure(s): AbbVie/Abbott: Advisor or Review Panel Member (Ongoing); chemocentryx: Advisor or Review Panel Member (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Novartis: Advisor or Review Panel Member (Ongoing); sanofi: Consultant (Ongoing)

  • Eosinophilic Granulomatosis with Polyangiitis: Beyond Evidence-Based Medicine

    Monday, November 13, 2023
    4:00 PM – 4:20 PM PT

    Disclosure(s): AbbVie/Abbott: Advisor or Review Panel Member (Ongoing); chemocentryx: Advisor or Review Panel Member (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Novartis: Advisor or Review Panel Member (Ongoing); sanofi: Consultant (Ongoing)

  • The Transition from Residency to Fellowship: Enhancing Training by Increasing Transparency

    Tuesday, November 14, 2023
    7:45 AM – 8:00 AM PT

    Disclosure(s): AbbVie/Abbott: Advisor or Review Panel Member (Ongoing); chemocentryx: Advisor or Review Panel Member (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Novartis: Advisor or Review Panel Member (Ongoing); sanofi: Consultant (Ongoing)